Effect of yohimbine on detomidine induced changes in behavior, cardiac and blood parameters in the horse

Heather K Knych, Vanessa Covarrubias, Eugene Steffey

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective To describe selected pharmacodynamic effects of detomidine and yohimbine when administered alone and in sequence. Study design Randomized crossover design. Animals Nine healthy adult horses aged 9±4years and weighing 561±56kg. Methods Three dose regimens were employed in the current study. 1) 0.03mgkg-1 detomidine IV, 2) 0.2mgkg-1 yohimbine IV and 3) 0.03mgkg-1 detomidine IV followed 15minutes later by 0.2mgkg-1 yohimbine IV. Each horse received all three treatments with a minimum of 1week between treatments. Blood samples were obtained and plasma analyzed for detomidine and yohimbine concentrations by liquid chromatography-mass spectrometry. Behavioral effects, heart rate and rhythm, glucose, packed cell volume and plasma proteins were monitored. Results Yohimbine rapidly reversed the sedative effects of detomidine in the horse. Additionally, yohimbine effectively returned heart rate and the percent of atrio-ventricular conduction disturbances to pre-detomidine values when administered 15minutes post-detomidine administration. Plasma glucose was significantly increased following detomidine administration. The detomidine induced hyperglycemia was effectively reduced by yohimbine administration. Effects on packed cell volume and plasma proteins were variable. Conclusions and clinical relevance Intravenous administration of yohimbine effectively reversed detomidine induced sedation, bradycardia, atrio-ventricular heart block and hyperglycemia.

Original languageEnglish (US)
Pages (from-to)574-583
Number of pages10
JournalVeterinary Anaesthesia and Analgesia
Volume39
Issue number6
DOIs
StatePublished - Nov 2012

Fingerprint

detomidine
yohimbine
Yohimbine
behavior change
Horses
horses
blood
hyperglycemia
Cell Size
Hyperglycemia
blood proteins
hematocrit
Blood Proteins
heart rate
Heart Rate
Glucose
glucose
Heart Block
sedatives
sedation

Keywords

  • Alpha-2 adrenergic agonist
  • Antagonist
  • Cardiac arrhythmias
  • Detomidine
  • Equine
  • Yohimbine

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Effect of yohimbine on detomidine induced changes in behavior, cardiac and blood parameters in the horse. / Knych, Heather K; Covarrubias, Vanessa; Steffey, Eugene.

In: Veterinary Anaesthesia and Analgesia, Vol. 39, No. 6, 11.2012, p. 574-583.

Research output: Contribution to journalArticle

@article{a8d35e2c0c734c5fadc04151a8a234ea,
title = "Effect of yohimbine on detomidine induced changes in behavior, cardiac and blood parameters in the horse",
abstract = "Objective To describe selected pharmacodynamic effects of detomidine and yohimbine when administered alone and in sequence. Study design Randomized crossover design. Animals Nine healthy adult horses aged 9±4years and weighing 561±56kg. Methods Three dose regimens were employed in the current study. 1) 0.03mgkg-1 detomidine IV, 2) 0.2mgkg-1 yohimbine IV and 3) 0.03mgkg-1 detomidine IV followed 15minutes later by 0.2mgkg-1 yohimbine IV. Each horse received all three treatments with a minimum of 1week between treatments. Blood samples were obtained and plasma analyzed for detomidine and yohimbine concentrations by liquid chromatography-mass spectrometry. Behavioral effects, heart rate and rhythm, glucose, packed cell volume and plasma proteins were monitored. Results Yohimbine rapidly reversed the sedative effects of detomidine in the horse. Additionally, yohimbine effectively returned heart rate and the percent of atrio-ventricular conduction disturbances to pre-detomidine values when administered 15minutes post-detomidine administration. Plasma glucose was significantly increased following detomidine administration. The detomidine induced hyperglycemia was effectively reduced by yohimbine administration. Effects on packed cell volume and plasma proteins were variable. Conclusions and clinical relevance Intravenous administration of yohimbine effectively reversed detomidine induced sedation, bradycardia, atrio-ventricular heart block and hyperglycemia.",
keywords = "Alpha-2 adrenergic agonist, Antagonist, Cardiac arrhythmias, Detomidine, Equine, Yohimbine",
author = "Knych, {Heather K} and Vanessa Covarrubias and Eugene Steffey",
year = "2012",
month = "11",
doi = "10.1111/j.1467-2995.2012.00776.x",
language = "English (US)",
volume = "39",
pages = "574--583",
journal = "Veterinary Anaesthesia and Analgesia",
issn = "1467-2987",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Effect of yohimbine on detomidine induced changes in behavior, cardiac and blood parameters in the horse

AU - Knych, Heather K

AU - Covarrubias, Vanessa

AU - Steffey, Eugene

PY - 2012/11

Y1 - 2012/11

N2 - Objective To describe selected pharmacodynamic effects of detomidine and yohimbine when administered alone and in sequence. Study design Randomized crossover design. Animals Nine healthy adult horses aged 9±4years and weighing 561±56kg. Methods Three dose regimens were employed in the current study. 1) 0.03mgkg-1 detomidine IV, 2) 0.2mgkg-1 yohimbine IV and 3) 0.03mgkg-1 detomidine IV followed 15minutes later by 0.2mgkg-1 yohimbine IV. Each horse received all three treatments with a minimum of 1week between treatments. Blood samples were obtained and plasma analyzed for detomidine and yohimbine concentrations by liquid chromatography-mass spectrometry. Behavioral effects, heart rate and rhythm, glucose, packed cell volume and plasma proteins were monitored. Results Yohimbine rapidly reversed the sedative effects of detomidine in the horse. Additionally, yohimbine effectively returned heart rate and the percent of atrio-ventricular conduction disturbances to pre-detomidine values when administered 15minutes post-detomidine administration. Plasma glucose was significantly increased following detomidine administration. The detomidine induced hyperglycemia was effectively reduced by yohimbine administration. Effects on packed cell volume and plasma proteins were variable. Conclusions and clinical relevance Intravenous administration of yohimbine effectively reversed detomidine induced sedation, bradycardia, atrio-ventricular heart block and hyperglycemia.

AB - Objective To describe selected pharmacodynamic effects of detomidine and yohimbine when administered alone and in sequence. Study design Randomized crossover design. Animals Nine healthy adult horses aged 9±4years and weighing 561±56kg. Methods Three dose regimens were employed in the current study. 1) 0.03mgkg-1 detomidine IV, 2) 0.2mgkg-1 yohimbine IV and 3) 0.03mgkg-1 detomidine IV followed 15minutes later by 0.2mgkg-1 yohimbine IV. Each horse received all three treatments with a minimum of 1week between treatments. Blood samples were obtained and plasma analyzed for detomidine and yohimbine concentrations by liquid chromatography-mass spectrometry. Behavioral effects, heart rate and rhythm, glucose, packed cell volume and plasma proteins were monitored. Results Yohimbine rapidly reversed the sedative effects of detomidine in the horse. Additionally, yohimbine effectively returned heart rate and the percent of atrio-ventricular conduction disturbances to pre-detomidine values when administered 15minutes post-detomidine administration. Plasma glucose was significantly increased following detomidine administration. The detomidine induced hyperglycemia was effectively reduced by yohimbine administration. Effects on packed cell volume and plasma proteins were variable. Conclusions and clinical relevance Intravenous administration of yohimbine effectively reversed detomidine induced sedation, bradycardia, atrio-ventricular heart block and hyperglycemia.

KW - Alpha-2 adrenergic agonist

KW - Antagonist

KW - Cardiac arrhythmias

KW - Detomidine

KW - Equine

KW - Yohimbine

UR - http://www.scopus.com/inward/record.url?scp=84867191328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867191328&partnerID=8YFLogxK

U2 - 10.1111/j.1467-2995.2012.00776.x

DO - 10.1111/j.1467-2995.2012.00776.x

M3 - Article

C2 - 23035904

AN - SCOPUS:84867191328

VL - 39

SP - 574

EP - 583

JO - Veterinary Anaesthesia and Analgesia

JF - Veterinary Anaesthesia and Analgesia

SN - 1467-2987

IS - 6

ER -